 SAN DIEGO, Nov. 20, 2020 PRNewswire -- Biocept, Inc. Nasdaq: BIOC, a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces the results of a study... 